Moataz Ellithi

411 total citations
25 papers, 153 citations indexed

About

Moataz Ellithi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Moataz Ellithi has authored 25 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Moataz Ellithi's work include CAR-T cell therapy research (4 papers), Complement system in diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Moataz Ellithi is often cited by papers focused on CAR-T cell therapy research (4 papers), Complement system in diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Moataz Ellithi collaborates with scholars based in United States and Pakistan. Moataz Ellithi's co-authors include Magdi Elsallab, Russell A. Wilke, Mohamed Abdallah, Hisham Abdel‐Azim, Mohamed Abou‐El‐Enein, Susanne Hempel, R. Gregory Bociek, Avyakta Kallam, Valerie Shostrom and Hafez Mohammad Ammar Abdullah and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Moataz Ellithi

22 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moataz Ellithi United States 7 69 35 29 29 21 25 153
Rabia Agca Netherlands 8 35 0.5× 11 0.3× 29 1.0× 45 1.6× 32 1.5× 17 178
Khalil Katato United States 6 33 0.5× 49 1.4× 29 1.0× 16 0.6× 63 3.0× 18 172
Angel YS Wong United Kingdom 4 60 0.9× 10 0.3× 10 0.3× 19 0.7× 22 1.0× 5 162
H. Bennani France 5 23 0.3× 13 0.4× 13 0.4× 15 0.5× 53 2.5× 14 161
Alejandra Villamil Argentina 5 25 0.4× 30 0.9× 17 0.6× 22 0.8× 19 0.9× 15 182
Yuqing Miao China 8 56 0.8× 24 0.7× 44 1.5× 53 1.8× 70 3.3× 22 228
Elisa Seneca Italy 4 20 0.3× 59 1.7× 13 0.4× 24 0.8× 40 1.9× 8 204
Anna Morelli Italy 7 56 0.8× 7 0.2× 14 0.5× 7 0.2× 31 1.5× 19 153
R.J. Hohl United States 8 38 0.6× 29 0.8× 9 0.3× 22 0.8× 50 2.4× 10 184

Countries citing papers authored by Moataz Ellithi

Since Specialization
Citations

This map shows the geographic impact of Moataz Ellithi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moataz Ellithi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moataz Ellithi more than expected).

Fields of papers citing papers by Moataz Ellithi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moataz Ellithi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moataz Ellithi. The network helps show where Moataz Ellithi may publish in the future.

Co-authorship network of co-authors of Moataz Ellithi

This figure shows the co-authorship network connecting the top 25 collaborators of Moataz Ellithi. A scholar is included among the top collaborators of Moataz Ellithi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moataz Ellithi. Moataz Ellithi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ellithi, Moataz, et al.. (2025). Care of Older Adults with Acute Myeloid Leukemia: The Role of Geriatric Assessment. Current Treatment Options in Oncology. 26(10). 920–927. 1 indexed citations
3.
Ellithi, Moataz, Magdi Elsallab, Matthew A. Lunning, et al.. (2024). Neurotoxicity and Rare Adverse Events in BCMA-Directed CAR T Cell Therapy: A Comprehensive Analysis of Real-World FAERS Data. Transplantation and Cellular Therapy. 31(2). 71.e1–71.e14. 11 indexed citations
4.
Ellithi, Moataz, et al.. (2024). Metabolic syndrome and symptom burden in allogeneic hematopoietic stem cell transplantation survivors. Future Oncology. 20(40). 3403–3408. 1 indexed citations
5.
Elsallab, Magdi, Moataz Ellithi, Susanne Hempel, Hisham Abdel‐Azim, & Mohamed Abou‐El‐Enein. (2023). Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systematic review and meta-analysis. Cancer Gene Therapy. 30(6). 845–854. 32 indexed citations
6.
Ali, Mohammad Javed, et al.. (2023). Impact of Acute Coronary Syndrome on Clinical Outcomes in Patients With Thrombotic Thrombocytopenic Purpura. Cureus. 15(3). e35878–e35878. 1 indexed citations
7.
Abdullah, Hafez Mohammad Ammar, et al.. (2023). Primary small cell neuroendocrine cancer of adrenal gland: a rare extrapulmonary small cell cancer. BMJ Case Reports. 16(2). e250828–e250828. 1 indexed citations
8.
Ellithi, Moataz, et al.. (2022). Abstract 3724: PBRM1 loss in RCC: Implications for immunotherapy. Cancer Research. 82(12_Supplement). 3724–3724. 1 indexed citations
9.
Ellithi, Moataz, et al.. (2022). The evolution of clinical outcomes in metastatic pancreatic adenocarcinoma: a 10-year experience at a tertiary referral center. Expert Review of Gastroenterology & Hepatology. 16(5). 479–486. 2 indexed citations
10.
Ellithi, Moataz, et al.. (2021). Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database. Annals of Hematology. 100(10). 2513–2519. 26 indexed citations
11.
Ullah, Waqas, Sohaib Roomi, Rehan Saeed, et al.. (2021). Impact of Body Mass Index on COVID-19-Related In-Hospital Outcomes and Mortality. Journal of Clinical Medicine Research. 13(4). 230–236. 4 indexed citations
12.
Abdullah, Hafez Mohammad Ammar, Moataz Ellithi, & Faiz Anwer. (2021). Clinical Outcomes in Patients Admitted with Malignancy Associated Hemophagocytic Lymphohistiocytosis (HLH). Blood. 138(Supplement 1). 4199–4199. 2 indexed citations
13.
Ellithi, Moataz, et al.. (2020). Differential Effects of Clinically Relevant N- versus C-Terminal Truncating CDKN1A Mutations on Cisplatin Sensitivity in Bladder Cancer. Molecular Cancer Research. 19(3). 403–413. 5 indexed citations
14.
Abdallah, Mohamed, et al.. (2020). Pulmonary Adenocarcinoma Presenting as a Pineal Gland Mass With Obstructive Hydrocephalus. Ochsner Journal. 20(2). 232–235. 3 indexed citations
15.
Ellithi, Moataz, et al.. (2020). Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More. Cureus. 12(2). e6935–e6935. 20 indexed citations
16.
Ellithi, Moataz, et al.. (2020). Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. Hematology Transfusion and Cell Therapy. 43(3). 364–367. 1 indexed citations
17.
Ellithi, Moataz, et al.. (2020). Acute Coronary Syndrome in Patients with Thrombotic Thrombocytopenic Purpura. Blood. 136(Supplement 1). 4–5. 1 indexed citations
18.
Ellithi, Moataz, et al.. (2020). Clinical characteristics and outcomes of signet ring cell carcinoma of the stomach: A retrospective analysis of SEER database.. Journal of Clinical Oncology. 38(15_suppl). e16572–e16572. 1 indexed citations
19.
Ellithi, Moataz, et al.. (2020). Survival analysis of CLL/SLL patients with Richter’s transformation to DLBCL: An analysis of the SEER database.. Journal of Clinical Oncology. 38(15_suppl). e20024–e20024.
20.
Abdallah, Mohamed, et al.. (2019). Turmeric-Associated Liver Injury. American Journal of Therapeutics. 27(6). e642–e645. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026